APA (7th ed.) Citation

Yao, R., Zhang, M., Zhou, J., Liu, L., Zhang, Y., Gao, J., & Xu, K. (2022). Novel dual-targeting c-Myc inhibitor D347-2761 represses myeloma growth via blocking c-Myc/Max heterodimerization and disturbing its stability. Cell Communication & Signaling, 20(1), 1. https://doi.org/10.1186/s12964-022-00868-6

Chicago Style (17th ed.) Citation

Yao, Ruosi, Menghui Zhang, Jian Zhou, Linlin Liu, Yan Zhang, Jian Gao, and Kailin Xu. "Novel Dual-targeting C-Myc Inhibitor D347-2761 Represses Myeloma Growth via Blocking C-Myc/Max Heterodimerization and Disturbing Its Stability." Cell Communication & Signaling 20, no. 1 (2022): 1. https://doi.org/10.1186/s12964-022-00868-6.

MLA (9th ed.) Citation

Yao, Ruosi, et al. "Novel Dual-targeting C-Myc Inhibitor D347-2761 Represses Myeloma Growth via Blocking C-Myc/Max Heterodimerization and Disturbing Its Stability." Cell Communication & Signaling, vol. 20, no. 1, 2022, p. 1, https://doi.org/10.1186/s12964-022-00868-6.